Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Some patients respond exceptionally well to semaglutide
Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity since the US Food & Drug Administration first approved semaglutide (brand name Ozempic/Wegovy) for weight loss in 2021
Leveraging our technical proficiency, we ensure our customers receive superior products and services
Are compounded semaglutide and tirzepatide FDA-approved
it was followed by semaglutide (Wegovy) and tirzepatide (Mounjaro) in 2021 and 2022, respectively
US$ 23.93
US$ 25.50
US$ 22.29
US$ 26.01
US$ 23.20
US$ 21.38
